If you bought Prevagen on claims it will boost your memory, you may have been a victim of false advertising.
Quincy Bioscience, manufacturer of Prevagen, has been advertising Prevagen as a memory supplement based on apoaequorin, a glowing jellyfish protein, and claiming that the product enters the human brain. In TV advertisements, the manufacturer touts alleged rapid and dramatic improvement in memory of Prevagen users based on a clinical study.
The Federal Trade Commission and the New York Attorney General have found these claims to be false. The same clinical study showed no statistically significant memory improvement in the treatment group over the placebo group. Moreover, there is no evidence that orally-administered apoaequorin enters the human brain. The Alzheimer’s Association did not specifically comment on Prevagen, but had serious concerns about the effectiveness and safety of dietary supplements in general as treatments for Alzheimer’s disease and other dementias, and the risk of adverse interactions with prescribed medications.
If you purchased Prevagen, please contact Finkelstein, Blankinship, Frei-Pearson & Garber to discuss your legal options. FBFG has successfully prosecuted false advertising claims on behalf of consumers.